| Key Financial Ratios of Alembic Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
29.68 |
31.33 |
17.40 |
26.50 |
60.81 |
|
| Diluted EPS (Rs.) |
29.68 |
31.33 |
17.40 |
26.50 |
60.81 |
|
| Cash EPS (Rs.) |
43.74 |
45.25 |
32.99 |
40.83 |
66.05 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
264.10 |
245.14 |
222.36 |
266.47 |
257.80 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
264.10 |
245.14 |
222.36 |
266.47 |
257.80 |
|
| Revenue from Operations/Share (Rs.) |
339.46 |
316.90 |
287.59 |
269.95 |
274.39 |
|
| PBDIT/Share (Rs.) |
53.46 |
48.93 |
36.18 |
47.04 |
79.75 |
|
| PBIT/Share (Rs.) |
39.29 |
35.05 |
22.17 |
32.45 |
70.42 |
|
| PBT/Share (Rs.) |
35.94 |
32.20 |
19.61 |
31.55 |
69.60 |
|
| Net Profit/Share (Rs.) |
29.57 |
31.38 |
18.97 |
26.24 |
56.72 |
|
| NP After MI And SOA / Share (Rs.) |
29.68 |
31.33 |
17.40 |
26.50 |
59.94 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
15.74 |
15.43 |
12.58 |
17.42 |
29.06 |
|
| PBIT Margin (%) |
11.57 |
11.06 |
7.70 |
12.02 |
25.66 |
|
| PBT Margin (%) |
10.58 |
10.15 |
6.82 |
11.68 |
25.36 |
|
| Net Profit Margin (%) |
8.71 |
9.90 |
6.59 |
9.71 |
20.67 |
|
| NP After MI And SOA Margin (%) |
8.74 |
9.88 |
6.05 |
9.81 |
21.84 |
|
| Return on Networth/Equity (%) |
11.23 |
12.78 |
7.82 |
9.94 |
22.97 |
|
| Return on Capital Employed (%) |
14.40 |
13.80 |
9.58 |
11.79 |
25.49 |
|
| Return on Assets (%) |
7.50 |
9.55 |
5.53 |
7.31 |
17.56 |
|
| Total Debt/Equity (X) |
0.23 |
0.09 |
0.15 |
0.12 |
0.04 |
|
| Asset Turnover Ratio (%) |
0.94 |
0.99 |
0.78 |
0.73 |
80.38 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.69 |
2.12 |
1.78 |
1.67 |
2.01 |
|
| Quick Ratio (X) |
0.75 |
0.99 |
0.88 |
0.73 |
0.85 |
|
| Inventory Turnover Ratio (X) |
0.85 |
0.90 |
0.87 |
0.78 |
3.63 |
|
| Dividend Payout Ratio (NP) (%) |
37.06 |
25.53 |
57.47 |
52.82 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
25.08 |
17.69 |
31.83 |
34.06 |
0.00 |
|
| Earnings Retention Ratio (%) |
62.94 |
74.47 |
42.53 |
47.18 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
74.92 |
82.31 |
68.17 |
65.94 |
0.00 |
|
| Coverage Ratios |
|
|
|
|
|
|
| Interest Coverage Ratios (%) |
13.34 |
17.11 |
14.17 |
52.15 |
86.40 |
|
| Interest Coverage Ratios (Post Tax) (%) |
13.34 |
17.11 |
14.17 |
52.15 |
86.40 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
19,368.46 |
19,611.97 |
10,301.50 |
15,131.79 |
19,003.45 |
|
| EV/Net Operating Revenue (X) |
2.90 |
3.15 |
1.82 |
2.85 |
3.52 |
|
| EV/EBITDA (X) |
18.43 |
20.39 |
14.49 |
16.37 |
12.12 |
|
| MarketCap/Net Operating Revenue (X) |
2.74 |
3.10 |
1.72 |
2.75 |
3.52 |
|
| Retention Ratios (%) |
62.93 |
74.46 |
42.52 |
47.17 |
0.00 |
|
| Price/BV (X) |
3.52 |
4.01 |
2.23 |
2.78 |
3.70 |
|
| Price/Net Operating Revenue |
2.74 |
3.10 |
1.72 |
2.75 |
3.52 |
|
| Earnings Yield |
0.03 |
0.03 |
0.04 |
0.04 |
0.06 |
|
Source : Dion Global Solutions Limited
